Geron Corp (GERN)

[Joda]

The SP is a hard call on GERN, always has been, that is why it is not a good stock to trade...it does not follow much logic.

For a long investor like myself, this latest move indicates to me that they can now proceed unhindered by the Hold the FDA put on them, as it no longer applies.

So they get an IND and apply for P2 trials...then they will be looked on for partnership.

Once results start coming from P2, maybe even before with the aging demographics we have, and then, if the longs are right, the price per share would be in a different class than today.

It is a hard call to trade or not, especially as I have been in a loss position for most of my time in GERN.
But these downs I can live with and they won't change my life.

What I could not live with is to be given a chance to invest in a world changing technology, and traded out my position for some meager gains.
Then watch the technology take over the world and others get rich.
THAT I could not live with comfortably...

So each to their own...in my opinion...

Why would Tefferi want to be so involved if there was not promise here..?
That's what I see...

another poster...
"Tefferi now wears two hats, as an employee of Mayo, and as the medical and scientific director at Geron responsible for MF studies (in progress and coming). The FDA has shown little confidence in Geron, while lifting the Mayo hold. Our investment is in "Tefferi Oncology Corp." for all practical purposes. Tefferi's skills will determine the future of Imetelstat, and the value of Geron. Mayo and the FDA do not want the research and viability of this medicine lessened by inexperienced hands. It is too important as part of a breakthrough technology."